• Cy3-UTP for Fluorescent RNA Labeling

  2026-09-28

  Cy3-UTP is a Cy3-modified uridine triphosphate for producing fluorescent RNA during in vitro transcription. Its reported water solubility, 95% purity, and light-protected storage requirement support imaging, RNA-protein interaction studies, and RNA detection assay workflows when appropriate controls are used.

• Sulfamonomethoxine Toxicity Across Aquatic Trophic Levels

  2026-09-28

  Huang and colleagues tested sulfamonomethoxine (SMM) across algae, cladocerans, and medaka, extending aquatic toxicity evidence beyond a single organism group. Their reported results identify microalgae as more sensitive than cladocerans in the assays summarized, while also showing why endpoint, exposure duration, and species must be considered when interpreting ecological risk.

• LY2886721: Practical BACE1 Assay Workflows

  2026-09-27

  Use LY2886721 to connect BACE1 enzyme inhibition with amyloid-beta output and neuronal function—not just a single potency readout. This workflow pairs dose finding with secreted Aβ measurements and synaptic monitoring, helping researchers distinguish partial target engagement from stronger inhibition in Alzheimer’s disease models.

• Losartan Workflows for AT1 Signaling Research

  2026-09-26

  Use Losartan to test how AT1 receptor blockade shapes vascular responses, smooth muscle cell growth, and hypertension-related phenotypes. This workflow pairs practical dose-finding and troubleshooting with a careful comparison to recent diabetic-nephropathy research—without conflating distinct compounds or mechanisms.

• From Aβ42 Exposure to Causal AD Biology

  2026-09-25

  Amyloid β-Peptide (1-42) can anchor translational Alzheimer’s disease studies when researchers connect amyloid exposure to measurable neuronal mechanisms. This article examines how Aβ42 models can help investigate neurotoxicity, ion-channel effects, and ferroptosis-related hypotheses, while outlining design, controls, and interpretation strategies informed by a recent Keap1–Nrf2 study.

• Biotin (Vitamin B7): Mechanism and Research Use

  2026-09-25

  Biotin (Vitamin B7) is a coenzyme for five carboxylases involved in fatty acid synthesis and the metabolism of amino acids. This guide distinguishes its metabolic role from protein biotinylation and summarizes the A8010 product’s reported properties and handling.

• ATRX-Deficient Glioma: RTK and PDGFR Inhibitor Sensitivity

  2026-09-24

  A drug screen reported that ATRX-deficient high-grade glioma cells were more sensitive to several receptor tyrosine kinase and PDGFR inhibitors than ATRX-proficient cells. The study also found pronounced toxicity when RTK inhibitors were combined with temozolomide, supporting further investigation of ATRX status as a potential stratification factor—not as established clinical guidance.

• Firefly Luciferase mRNA as a Delivery Readout

  2026-09-24

  Firefly Luciferase mRNA can report successful protein expression, but its light output reflects more than mRNA uptake alone. This article connects the design of 5-moUTP modified mRNA with recent findings on immune-active delivery vehicles to help researchers interpret reporter assays with greater precision.

• NLRP10 Links Keratinocyte Survival to Skin Barrier Function

  2026-09-23

  A 2024 study identifies NLRP10 as a regulator of epidermal homeostasis, connecting keratinocyte survival with p63-dependent differentiation and barrier formation. Human skin samples and an air-lift skin-equivalent model support a mechanistic link between reduced NLRP10, caspase-8-associated cell death, and impaired epidermal function in atopic dermatitis.

• NLRP10, Keratinocyte Survival, and Skin Barrier

  2026-09-23

  The reference study identifies NLRP10 as a skin-intrinsic regulator of epidermal homeostasis, linking it to keratinocyte survival, p63-dependent differentiation, and barrier function. Using human atopic dermatitis samples and an air-lift human skin equivalent, the authors connect NLRP10 loss to caspase-8-mediated cell death and impaired epidermal maturation.

• Cyanidin Chloride for Oxidative Stress Workflows

  2026-09-22

  Cyanidin Chloride enables a practical progression from chemical radical assays to cell-based oxidative stress and barrier-function studies. This workflow distinguishes aglycone evidence from glycoside findings while using ROS, inflammatory, STAT3, qPCR, and TEER endpoints to build stronger mechanistic conclusions.

• Perospirone: From Receptors to Kv1.5

  2026-09-22

  Perospirone, also known as SM-9018 free base, combines 5-HT2A, D2, and 5-HT1A pharmacology with a newly characterized vascular Kv1.5 signal. This article explains how to interpret these mechanisms across schizophrenia research and cardiovascular assays without overstating translational evidence.

• (-)-Arctigenin: MEK1 Inhibitor Workflow

  2026-09-21

  Use (-)-Arctigenin as a titratable chemical probe to interrogate NF-κB and iNOS signaling alongside macrophage EV–miR-660 breast cancer assays. This workflow separates pathway modulation from EV cargo causality while adding practical controls for solvent handling, dosing, invasion readouts, and MEK1 studies.

• Amphotericin B in Reliable Cell Assays

  2026-09-21

  This scenario-driven guide explains how Amphotericin B (SKU B1885) can improve experimental planning for fungal susceptibility, biofilm, viability, and immune-cell assays. It connects membrane sterol biology, formulation constraints, storage, dose selection, and interpretation to practical laboratory decisions.

• Berberine, RAGE/POMC, and Glucolipid Metabolism

  2026-09-20

  This 2026 pre-proof study identifies RAGE/POMC signaling as a central mechanism through which berberine may protect hypothalamic neurons while improving glucolipid metabolism. By combining network pharmacology, mass spectrometry, cellular assays, and a mouse model, it links reduced neuronal apoptosis and increased autophagy with better glucose tolerance and lower serum triglycerides, although causal pathway validation remains incomplete.

8078 records 1/539 page Next 12345 下5页 Last page